FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
U.S. Food and Drug Administration
Roctavian recipients should be closely monitored for infusion-related reactions and liver enzyme elevation
IVDR-compliant products help boost patient safety as well as future-proof customer supply chains
Most LGBTQ+ advocates welcome FDA’s proposed blood donor eligibility guidance, despite its flaws
The technique needs only 20 μl of sample and can be configured to run on most liquid handling systems